Tom Maniatis has become scientific director and CEO of the New York Genome Center. He is the Isidore S. Edelman Professor of Biochemistry and chair of the Department of Biochemistry and Molecular Biophysics at Columbia University. He replaces Bob Darnell, who stepped down as CEO of the NYGC last year but remains a faculty member of the center. Maniatis had already served on the board of directors and in other leadership capacities at the NYGC since its inception.
Former 23andMe President Andy Page has joined consumer digital heath firm Livongo Health as its president and CFO. Page joined 23andMe in 2012 and became its president the following year. He left the company late last year. Prior to 23andMe, Page held several executive positions at other consumer technology companies, including president of Gilt Groupe, and CFO at PlayPhone and StubHub.
Brian Caveney will join Laboratory Corporation of America as enterprise-wide chief medical officer on Sept. 25. He will report to LabCorp Chairman and CEO David King. In the newly created role, Caveney will oversee LabCorp’s medical and scientific strategy, and serve as the company’s primary external medical representative, defining global standards for medical and scientific activities across LabCorp’s diagnostic and drug development businesses. Caveney is currently chief medical officer of Blue Cross and Blue Shield of North Carolina.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.